美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

YARROW BIOSCIENCE, INC.

36.43

-1.7750-4.65%

盘后：36.430.00000.00%19:30 EDT

成交量：2.60万

成交额：94.40万

市值：9,724.75万

市盈率：-1.67

高：38.38

开：37.00

低：35.50

收：38.20

52周最高：46.95

52周最低：14.03

股本：266.98万

流通股本：61.15万

量比：1.38

换手率：4.25%

股息：- -

股息率：- -

每股收益(TTM):-21.8600

每股收益(LYR):-66.8179

净资产收益率：--

总资产收益率：--

市净率：-1.37

市盈率(LYR):-0.55

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

YARROW BIOSCIENCE, INC.

交易所：

NASDAQ

成立时间：

2025

员工人数：

7

公司地址：

40 10 th Avenue,Floor 7,New York,New York,United States

官网：

http://www.yarrowbioscience.com

邮编：

10014

电话：

- -

传真：

- -

简介：

Yarrow Bioscience, Inc.于2011年10月作为特拉华州的一家公司注册成立。该公司是一家临床阶段的生物制药公司，专注于开发差异化疗法，以治疗存在高度未满足医疗需求的炎症性和免疫介导性疾病。Yarrow的专有BET抑制剂（构成其InhiBET平台）旨在通过利用替代给药途径和增强选择性来克服早期BET抑制剂的局限性。该公司也专注于开发自身免疫性甲状腺疾病的疗法，包括一种潜在的首创抗促甲状腺激素受体单克隆抗体，该抗体旨在直接破坏格雷夫斯病和甲状腺眼病的中心机制。

董事

名称

职位

Bill Lundberg

Chairman of the Board and Director

Rebecca Frey

Chief Executive Officer and Director and President

Mona Ashiya

Director

Peter Silverman

Director

Steven Hoerter

Director

William White

Director

股东

名称

职位

Rebecca Frey

Chief Executive Officer and Director and President

Rachael Alford

Chief Operating Officer

Tyler Zeronda

Chief Financial Officer

Lori Payton

Chief Development Officer

Steven Ryder

Chief Medical Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/YARW/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"YARW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YARW\",,,,,undefined,":{"symbol":"YARW","market":"US","secType":"STK","nameCN":"YARROW BIOSCIENCE, INC.","latestPrice":36.425,"timestamp":1787342400000,"preClose":38.2,"halted":0,"volume":25981,"hourTrading":{"tag":"盘后","latestPrice":36.425,"preClose":36.425,"latestTime":"19:30 EDT","volume":10,"amount":369.5,"timestamp":1787355005444,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04646596858638758,"floatShares":611500,"shares":2669800,"eps":-21.86,"marketStatus":"休市中","change":-1.775,"latestTime":"08-21 16:00:00 EDT","open":37,"high":38.38,"low":35.5,"amount":943966.2960069999,"amplitude":0.075393,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-21.86,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1516856400000,"exchange":"NASDAQ","adjPreClose":38.2,"postHourTrading":{"tag":"盘后","latestPrice":36.425,"preClose":36.425,"latestTime":"19:30 EDT","volume":10,"amount":369.5,"timestamp":1787355005444,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3824092677883641},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YARW\",,,,,undefined,":{"symbol":"YARW","floatShares":611500,"roa":"--","roe":"--","lyrEps":-66.817882,"volumeRatio":1.3824092677883641,"shares":2669800,"dividePrice":0,"high":38.38,"amplitude":0.075393,"preClose":38.2,"low":35.5,"week52Low":14.025,"pbRate":"-1.37","week52High":46.95,"institutionHeld":0,"latestPrice":36.425,"eps":-21.86,"divideRate":0,"volume":25981,"delay":0,"ttmEps":-21.86,"open":37,"prevYearClose":29.005,"prevWeekClose":42.49,"prevMonthClose":35.02,"prevQuarterClose":32.535,"fiveDayClose":42.49,"twentyDayClose":25.45,"sixtyDayClose":33.995},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/YARW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"YARW","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-2.14},{"market":"US","date":"2026-07-27","symbol":"YARW","defaultRemindTime":1785159000000,"type":"split","dateTimestamp":1785124800000,"forFactor":50,"toFactor":1,"ratio":50},{"date":"2026-07-24","symbol":"YARW","amount":0.40242,"announcedDate":"2026-07-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-22","defaultRemindTime":1784899800000,"name":"VYNE Therapeutics Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-23","payableDate":"2026-07-22","currency":"USD","dateTimestamp":1784865600000,"payDate":"2026-07-23"},{"market":"US","date":"2026-05-15","symbol":"YARW","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.08},{"date":"2026-02-27","symbol":"YARW","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772182800000,"name":null,"time":"盘前","dateTimestamp":1772168400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"YARW\",market:\"US\",,,undefined,":[{"executeDate":"2026-07-24","recordDate":"2026-07-22","paymentDate":"2026-07-23","value":0.40242,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"YARW\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1786680000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/YARW\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"YARW","date":"2026-08-21","current":-1.666285,"percent":1,"low":-0.423388,"twenty":-0.421318,"median":-0.411606,"eighty":-0.406626,"high":-0.376652,"avg":-0.410215,"sd":0.013222,"marketCap":106960000},"quantilePoints":[{"date":"2026-08-14","current":-0.421219,"twenty":-0.422047,"median":-0.421219,"eighty":-0.412759,"marketCap":119616000},{"date":"2026-08-21","current":-0.376652,"twenty":-0.421318,"median":-0.411606,"eighty":-0.406626,"marketCap":106960000}],"updateTime":1787480624036},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1974571740,"yearFounded":2025,"employeeNum":7,"address":"40 10 th Avenue,Floor 7,New York,New York,United States","zipCode":"10014","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.yarrowbioscience.com","stockEarnings":[{"period":"1week","weight":-0.1427},{"period":"1month","weight":-0.1884},{"period":"3month","weight":0.085},{"period":"6month","weight":0.2248},{"period":"1year","weight":1.2568},{"period":"ytd","weight":0.2558}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Yarrow Bioscience, Inc.于2011年10月作为特拉华州的一家公司注册成立。该公司是一家临床阶段的生物制药公司，专注于开发差异化疗法，以治疗存在高度未满足医疗需求的炎症性和免疫介导性疾病。Yarrow的专有BET抑制剂（构成其InhiBET平台）旨在通过利用替代给药途径和增强选择性来克服早期BET抑制剂的局限性。该公司也专注于开发自身免疫性甲状腺疾病的疗法，包括一种潜在的首创抗促甲状腺激素受体单克隆抗体，该抗体旨在直接破坏格雷夫斯病和甲状腺眼病的中心机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.037101},{"month":2,"riseRate":0.444444,"avgChangeRate":0.014686},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.004341},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.154087},{"month":5,"riseRate":0.555556,"avgChangeRate":0.00572},{"month":6,"riseRate":0.111111,"avgChangeRate":-0.050475},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.128315},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.071725},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023153},{"month":10,"riseRate":0.5,"avgChangeRate":0.011012},{"month":11,"riseRate":0.5,"avgChangeRate":-0.029442},{"month":12,"riseRate":0.375,"avgChangeRate":-0.029662}],"exchange":"NASDAQ","name":"YARROW BIOSCIENCE, INC.","nameEN":"YARROW BIOSCIENCE, INC."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"YARW\",market:\"US\",,,undefined,":{"directors":[{"name":"Bill Lundberg","position":"Chairman of the Board and Director"},{"name":"Rebecca Frey","position":"Chief Executive Officer and Director and President"},{"name":"Mona Ashiya","position":"Director"},{"name":"Peter Silverman","position":"Director"},{"name":"Steven Hoerter","position":"Director"},{"name":"William White","position":"Director"}],"executives":[{"name":"Rebecca Frey","position":"Chief Executive Officer and Director and President"},{"name":"Rachael Alford","position":"Chief Operating Officer"},{"name":"Tyler Zeronda","position":"Chief Financial Officer"},{"name":"Lori Payton","position":"Chief Development Officer"},{"name":"Steven Ryder","position":"Chief Medical Officer"}]}}}